| abstract |
The present invention relates to compounds comprising peptides and peptidomimetics having antifungal activity alone, and compounds comprising in combination with other agents having antifungal activity. The present invention encompasses the use of cell cycle G2 checkpoint suppressors as antifungal agents (eg, antifungal agents). The antifungal compounds of the present invention are useful for the treatment of fungi (eg, killing yeast, mold, slime molds or inhibiting their growth). These compounds can be used to treat any subject or organism that has or is at risk of unwanted fungal contact, contamination, growth, growth, or infection. |